In consultation: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Decitabine–cedazuridine with venetoclax for treating acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |